Whats new
Whats new.
Maxim Group - Disappointing Data for TIGIT; Nice Set up for Immutep’s soluble LAG-3 in 1L NSCLC? ASCO is Next (Analyst: Dr Naureen Quibria)
May 12th 2022
For a copy of this analyst report please contact your Maxim advisor John Law - jlaw@maximgrp.com or biotech analyst Naureen Quibria - nquibria@maximgrp.com